EFFICACY AND SAFETY OF SPARSENTAN (RE-021), A DUAL ENDOT

  • Rheault, Michelle (PI)

Project: Research project

Project Details

Description

EFFICACY AND SAFETY OF SPARSENTAN (RE-021), A DUAL ENDOTHELIN RECEPTOR AND ANGIOTENSIN RECEPTOR BLOCKER, IN PATIENTS WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS): A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROL, DOSE-ESCALATION STUDY
StatusActive
Effective start/end date3/15/152/28/22

Funding

  • RETROPHIN INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.